Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report

被引:9
作者
Giorgio, Valentina [1 ]
Blasi, Elisa [1 ]
Rigante, Donato [1 ,2 ]
Guerriero, Cristina [3 ]
De Simone, Clara [2 ,3 ]
Fedele, Anna Laura [4 ]
Stella, Giuseppe [1 ]
Gasbarrini, Antonio [2 ,5 ]
Scaldaferri, Franco [5 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Life Sci & Global Hlth, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, I-00168 Rome, Italy
[3] Fdn Policlin Univ A Gemelli IRCCS, Inst Dermatol, I-00168 Rome, Italy
[4] Fdn Policlin Univ A Gemelli IRCCS, Inst Rheumatol, I-00168 Rome, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Internal Med, I-00168 Rome, Italy
关键词
leukocytoclastic vasculitis; ulcerative colitis; purpura; tumor necrosis factor; EXTRAINTESTINAL MANIFESTATIONS; CUTANEOUS VASCULITIS; ANTAGONISTS; INFLIXIMAB; THERAPIES; PATIENT; RISK;
D O I
10.3390/ijerph18136711
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: The development of drugs directed against tumor necrosis factor (TNF)-alpha has dramatically modified the therapeutic approach to inflammatory bowel diseases: a larger use of such drugs has also led to a major knowledge about their adverse effects, especially on skin. The aim of this report was to describe a rare steroid-dependent form of leukocytoclastic vasculitis induced by an anti-TNF-alpha agent in a young woman with ulcerative colitis. Case presentation: A young girl with ulcerative colitis developed a form of leukocytoclastic vasculitis induced by an anti-TNF-alpha agent. Recurrent palpable purpuric lesions on her legs were the main cutaneous manifestation. Skin lesions were steroid-dependent, but improved after withdrawal of the anti-TNF-alpha agent and second-line immunosuppressant therapy. Conclusions: The need to develop specific recommendations to guide the use of medications for managing skin reactions induced by anti-TNF-alpha drugs is herein emphasized.
引用
收藏
页数:6
相关论文
共 29 条
[1]   Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].
Baert, F ;
Noman, M ;
Vermeire, S ;
Van Assche, G ;
D'Haens, G ;
Carbonez, A ;
Rutgeerts, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608
[2]  
Bernardes C, 2018, GASTROENT HEPAT-BARC, V41, P442, DOI [10.1016/j.gastrohep.2017.08.004, 10.1016/j.gastre.2018.06.011]
[3]   Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis [J].
Bouhuys, Marleen ;
Armbrust, Wineke ;
van Rheenen, Patrick F. .
FRONTIERS IN PEDIATRICS, 2021, 9
[4]   Leukocytoclastic vasculitis in an adolescent with ulcerative colitis: Report of a case and review of the literature [J].
Butts, G. Tyler ;
Bishop, Phyllis R. ;
Wyatt, Julie P. ;
Nowicki, Michael J. .
SAGE OPEN MEDICAL CASE REPORTS, 2014, 2
[5]   Cutaneous Vasculitis in a Patient with Crohn's Disease Treated with Adalimumab [J].
Cury, Didia B. ;
de Souza, Alexandre W. S. ;
Vianna, Giovanni A. ;
Odashiro, Danilo ;
Farias, Alex ;
Moss, Alan C. .
INFLAMMATORY BOWEL DISEASES, 2017, 23 (01) :E1-E2
[6]   The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies [J].
Deitch, Iris ;
Amer, Radgonde ;
Tomkins-Netzer, Oren ;
Habot-Wilner, Zohar ;
Friling, Ronit ;
Neumann, Ron ;
Kramer, Michal .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (04) :801-808
[7]   Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome [J].
Federico, G ;
Rigante, D ;
Pugliese, AL ;
Ranno, O ;
Catania, S ;
Stabile, A .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2003, 32 (05) :312-314
[8]   The yin and yang of TNF-α inhibition [J].
Fiorentino, David F. .
ARCHIVES OF DERMATOLOGY, 2007, 143 (02) :233-236
[9]  
Gonzalez-Gay MA, 2005, CURR OPIN RHEUMATOL, V17, P56
[10]   Childhood generalized pustular psoriasis: Successful long-term treatment with adalimumab [J].
Hansel, Katharina ;
Marietti, Rossella ;
Tramontana, Marta ;
Bianchi, Leonardo ;
Romita, Paolo ;
Giuffrida, Roberta ;
Stingeni, Luca .
DERMATOLOGIC THERAPY, 2020, 33 (03)